*001267912
*00520190426105748.0
*007ta
*008181005s2018    no a   e m    00  0 eng
*00901674nam a2200325 c 4500
*019  $bl
*020  $a978-82-326-3336-4$qheftet
*035  $a(EXLNZ-47BIBSYS_NETWORK)999920629896502201
*035  $a(NO-LaBS)14883056(bibid)
*040  $aNO-OsNB$bnob$erda
*0410 $aeng$bnob
*08204$a616.99418$223/nor$qNO-OsNB
*1001 $aBaranowska, Katarzyna Anna$d1965-$0(NO-TrBIB)1535375968748$4aut$_52968200
*24510$aMultiple myeloma-study of cellular sensitivity to proteasome inhibitors$cKatarzyna Anna Baranowska
*264 1$aTrondheim$bNorwegian University of Science and Technology, Faculty of Medicine and Health Sciences, Department of Clinical and Molecular Medicine$c2018
*300  $a1 bind (varierende paginering)$billustrasjoner$c25 cm
*336  $atekst$0http://rdaregistry.info/termList/RDAContentType/1020$2rdaco
*337  $auformidlet$0http://rdaregistry.info/termList/RDAMediaType/1007$2rdamt
*338  $abind$0http://rdaregistry.info/termList/RDACarrierType/1049$2rdact
*4901 $aDoctoral theses at NTNU$v2018:273$x1503-8181
*500  $aDelvis opptrykk av artikler
*502  $aAvhandling (ph.d.) - Norges teknisk-naturvitenskapelige universitet, Trondheim, 2018
*546  $aSammendrag på norsk
*653  $adoktoravhandlinger$aph.d$amedisin$aklinisk$amolekylær$amolekylærmedisin$_52968300
*7102 $aNorges teknisk-naturvitenskapelige universitet$0(NO-TrBIB)90866400$4pbl$_10132100
*7102 $aNorges teknisk-naturvitenskapelige universitet$bInstitutt for klinisk og molekylær medisin$0(NO-TrBIB)1498562807882$4dgg$_204434400
*830 0$aDoktoravhandlinger ved NTNU (trykt utg.)$x1503-8181$v2018:273$w990402410684702201$_10123500
*913  $aNorbok$bNB
*917  $ad
*999  $aoai:nb.bibsys.no:999919956972602202$b2021-11-14T20:06:08Z$z999919956972602202
^